| 6FYZ | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | EBE, NA, ZN | enzyme |
| ||||||||||||
| Primary reference | Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor., Luckhurst CA, Aziz O, Beaumont V, Burli RW, Breccia P, Maillard MC, Haughan AF, Lamers M, Leonard P, Matthews KL, Raphy G, Stott AJ, Munoz-Sanjuan I, Thomas B, Wall M, Wishart G, Yates D, Dominguez C, Bioorg Med Chem Lett. 2018 Nov 13. pii: S0960-894X(18)30858-8. doi:, 10.1016/j.bmcl.2018.11.009. PMID:30463802 | ||||||||||||||
| Data retrieval |
![]() |
| View 6FYZ in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |